 Retinopathy of Prematurity
"Retinopathy of Prematurity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
| Descriptor ID |
D012178
|
| MeSH Number(s) |
C11.768.836 C16.614.521.731
|
| Concept/Terms |
Retinopathy of Prematurity- Retinopathy of Prematurity
- Prematurity Retinopathies
- Prematurity Retinopathy
- Retrolental Fibroplasia
- Fibroplasia, Retrolental
- Fibroplasias, Retrolental
- Retrolental Fibroplasias
|
Below are MeSH descriptors whose meaning is more general than "Retinopathy of Prematurity".
Below are MeSH descriptors whose meaning is more specific than "Retinopathy of Prematurity".
This graph shows the total number of publications written about "Retinopathy of Prematurity" by people in this website by year, and whether "Retinopathy of Prematurity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 1 | 2 | | 2004 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2008 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 3 | 0 | 3 | | 2013 | 2 | 0 | 2 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 0 | 1 | | 2016 | 2 | 1 | 3 | | 2017 | 2 | 0 | 2 | | 2018 | 4 | 0 | 4 | | 2019 | 5 | 0 | 5 | | 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Retinopathy of Prematurity" by people in Profiles.
-
Blair MP, Rodriguez SH, Shapiro MJ. A Potential Solution to Plus Disease Variability. Ophthalmol Retina. 2020 10; 4(10):1022-1023.
-
Zhang MH, Blair MP, Ham SA, Rodriguez SH. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
-
Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
-
Hamad AE, Moinuddin O, Blair MP, Schechet SA, Shapiro MJ, Quiram PA, Mammo DA, Berrocal AM, Prakhunhungsit S, Cernichiaro-Espinosa LA, Mukai S, Yonekawa Y, Ung C, Holz ER, Harper CA, Young RC, Besirli CG, Nagiel A, Lee TC, Gupta MP, Walsh MK, Khawly JA, Campbell JP, Kychenthal A, Nudleman ED, Robinson JE, Hartnett ME, Calvo CM, Chang EY. Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity. Ophthalmol Retina. 2020 06; 4(6):602-612.
-
Rodriguez SH, Peyton C, Lewis K, Andrews B, Greenwald MJ, Schreiber MD, Msall ME, Blair MP. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
-
Tiryaki S, Garcia-Gonzalez JM, Zhang DL, Shapiro MJ, Blair MP. Foveal Development After Use of Bevacizumab for Aggressive Posterior Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):e185-e187.
-
Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
-
Garcia Gonzalez JM, Shapiro MJ, Blair MP. Reply. Retina. 2019 01; 39(1):e2-e4.
-
Theophanous C, Schechet S, Rodriguez SH, Blair M. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
-
Blair MP, Hilkert Rodriguez S, Chan RVP, Shapiro MJ. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|